Key Highlights

  • Lilly Bull 2X ETF (NASDAQ:ELIL) was quoted up 6.48% at USD 35.00 on October 22, 2026, with Eli Lilly due to report third quarter results on October 29, 2026 after second quarter Revenue of USD 22.97 billion, up 48%.
  • Lululemon 2X Long ETF (NASDAQ:LULG) was quoted up 9.28% at USD 4.12, even though Lululemon's second quarter comparable sales fell 9% and full year revenue is guided down 5% to 7%.
  • Rigetti 2x ETF (CBOE:RGTC) was quoted up 6.55% at USD 12.66, with Rigetti holding USD 541.3 million of cash and no Debt against second quarter revenue of only USD 5.1 million and an operating loss of USD 28.1 million.
  • Netflix Bull 2X ETF (NASDAQ:NFXL) was quoted up 6.70% at USD 12.74, although Netflix shares fell 5.31% on October 21 after it cut 2026 Advertising revenue expectations and free Cash Flow guidance on October 20, 2026.

Lilly Bull 2X ETF (NASDAQ:ELIL): Eli Lilly, obesity drug leader

Eli Lilly (NYSE:LLY) reported second quarter 2026 revenue of USD 22.97 billion, up 48% from a year earlier, led by Mounjaro and Zepbound. The stock traded near USD 1,268 on October 21, 2026, within a 52-week range of USD 793.82 to USD 1,311.75, according to published data, and recently hit a record before slipping. The Investment case rests on the obesity and diabetes franchise, where Demand has exceeded Supply and the company has invested heavily in manufacturing. Third quarter results on October 29, 2026 will show whether growth and margins continue, and whether guidance is lifted again as it was earlier in the year. Supply remains a focus. Lilly Bull 2X ETF (NASDAQ:ELIL) seeks twice Eli Lilly's daily return, so the quoted 6.48% gain implies a stock move near 3.2%. For Lilly Bull 2X ETF (NASDAQ:ELIL), the October 29, 2026 report is the next marker. Retatrutide is a once-weekly injection targeting three hormone receptors, compared with two for Zepbound. Phase 3 studies showed average weight loss of 22.6% over 80 weeks in patients with obesity and cardiovascular disease, up to 20.8% in patients with type 2 diabetes and 28.3% in non-diabetic patients at the highest dose.

Lululemon 2X Long ETF (NASDAQ:LULG): Lululemon, apparel turnaround

Lululemon Athletica (NASDAQ:LULU) reported second quarter fiscal 2026 results on September 3, 2026. Net revenue fell 4% to USD 2.4 billion, or 5% in constant dollars, and comparable sales fell 9%. Americas comparable sales fell 12%, while international revenue grew 4%. Gross Margin rose 200 basis points to 60.5%, but Tariff refunds of USD 134.5 million added about 560 basis points, so the underlying margin declined. Operating Income fell 13% to USD 453.7 million, and diluted Earnings were USD 2.92 compared with USD 3.10, including USD 0.86 from tariff refunds. The company repurchased 2.7 million shares for USD 330.0 million in the quarter, and third quarter revenue is guided down 10% to 11%. Lululemon 2X Long ETF (NASDAQ:LULG) aims for twice Lululemon's daily return, so the quoted gain of 9.28% implies a stock move near 4.6%. For Lululemon 2X Long ETF (NASDAQ:LULG), the December report is the next marker. Heidi O'Neill took over as chief executive in September 2026, succeeding the interim co-chief executives, and began overhauling the Leadership team in early October, including new roles for product and a president hired from Athleta, according to published trade reports. The latest move has no company release attached.

Rigetti 2x ETF (CBOE:RGTC): Rigetti, quantum computing

Rigetti Computing (NASDAQ:RGTI) reported second quarter 2026 results on August 6, 2026. Revenue was USD 5.1 million, the operating loss was USD 28.1 million, and the GAAP net loss was USD 52.6 million, or USD 0.16 per share, against a non-GAAP loss of USD 16.0 million. Cash, equivalents and investments were USD 541.3 million with no debt, which funds several years at the current burn. Technical progress on the Cepheus-1-108Q system included about 99.9% median single-qubit fidelity and about 99.1% median two-qubit fidelity at roughly 60 nanosecond gate speeds. The roadmap targets about 1,000 qubits at about 99.9% two-qubit fidelity within about three years. Burn remains significant. Rigetti 2x ETF (CBOE:RGTC) aims for twice Rigetti's daily return, so the quoted gain of 6.55% implies a stock move near 3.3%. For Rigetti 2x ETF (CBOE:RGTC), third quarter results and the Commerce agreement are the next markers. The company signed a letter of intent with the U.S. Department of Commerce for up to USD 100 million over three years, which contemplates an Equity stake for the Department, and plans investment of up to USD 100 million in the United Kingdom. A 9-qubit Novera system will go to the Pittsburgh Supercomputing Center under a collaboration with HPE. Published commentary noted that the stock fell about 21% in the month before October 18, 2026 as the quantum sector faced commercialization doubts.

Netflix Bull 2X ETF (NASDAQ:NFXL): Netflix, streaming results

Netflix (NASDAQ:NFLX) reported strong third quarter profit on October 20, 2026, with Operating Margin of 34.6% against 28.2% a year earlier and diluted earnings of USD 0.87 per share, but its outlook disappointed. Full year revenue guidance is USD 51.1 billion, about 0.2% below the prior midpoint, the fourth quarter operating margin is guided to 26.0% including about 120 basis points of drag from headcount reductions, and advertising revenue for 2026 is now expected near USD 2.7 billion because some ad capabilities are rolling out more slowly than planned. Free cash flow guidance fell to USD 12.0 billion, mainly because of an expected real estate transaction closing in the fourth quarter. Netflix Bull 2X ETF (NASDAQ:NFXL) seeks twice Netflix's daily return. For Netflix Bull 2X ETF (NASDAQ:NFXL), fourth quarter delivery of the 26.0% margin guide is the next marker. Netflix repurchased 63.9 million shares for USD 4.8 billion in the third quarter and has USD 22.3 billion of authorization left, a large backstop for demand for its stock. Wire reports on October 14, 2026 described a layoff of about 6% of employees, around 1,000 jobs.

Where Things Stand

The answer is that broad risk appetite and sector rebounds, not new company releases, explain most of these moves, and each fund doubled its stock's daily move. Lilly Bull 2X ETF (NASDAQ:ELIL) has the strongest fundamentals but a high valuation. Lululemon 2X Long ETF (NASDAQ:LULG) tracks a company with falling sales and a new chief executive. Rigetti 2x ETF (CBOE:RGTC) is a speculative quantum story. Netflix Bull 2X ETF (NASDAQ:NFXL) carries a quote that conflicts with the stock's session.